Podcasts about world tb day

Lester Kiewit speaks to Russell Rensburg, TB Accountability Consortium programme director, about their state of TB in South Africa Report. It was launched to coincide with international World TB Day. It also evaluates the government’s ambitious plan to test 5million people over the next year to bring it under control and reduce the annual 56 000 deaths in South Africa.See omnystudio.com/listener for privacy information.

Host: Darryl S. Chutka, M.D. Guest: James T. Gaensbauer, M.D., M.S. Each year, we recognize World TB Day on March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). World TB Day is a day to educate the public about the impact of TB around the world.  The CDC, along with our partners and colleagues around the world, share successes in TB prevention and control and raise awareness of the challenges that hinder our progress toward the elimination of this devastating disease. Tuberculosis continues to be a global health concern.  Despite being preventable and very treatable, this disease continues to cause suffering and death.  It accounted for an estimated one and a quarter million deaths worldwide in 2023. In the United States, cases have been increasing over the past several years, and this is also true in children, especially in those under the age of 5 years. What are the common risk factors for tuberculosis in children? Is the disease different in children compared to adults? What should we, as a primary care provider do when we suspect tuberculosis in a young patient? These are some of the questions I'll be asking my guest for this podcast, James T. Gaensbauer, M.D., M.S., a pediatric infectious disease specialist at the Mayo Clinic as we discuss “Tuberculosis in Children”. Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

Amelia Poulin, Assistant Director of Emerging Infectious Disease at ASTHO, gives an update on public health's battle against tuberculosis on World TB Day; Moses Pretrick, Assistant Secretary for Health for the Federated States of Micronesia, tells us how ASTHO's Executive Leadership Forum helps the island areas; ASTHO will host a webinar focused on how AmeriCorps is Shaping Public Health in Indiana on April 3. CDC Web Page: 2025 U.S. TB Elimination Champions ASTHO Webinar: Public Health in Action – How AmeriCorps is Shaping Public Health in Indiana and NACDD ASTHO Web Page: Stay Informed  

Marking World TB Day 2025, this episode explores the data on tuberculosis in Europe based on the latest surveillance report, published recently by ECDC and WHO.Veronica Cristea, Scientific Officer at ECDC, discusses the overall TB situation in the EU/EEA, the impact of COVID-19, challenges in treatment success, and the concerning rise in TB cases among children. Veronica also highlights the steps needed to accelerate progress towards ending TB.Find out more about World TB Day here.For more information about ECDC in general, visit ⁠⁠⁠ecdc.europa.eu⁠⁠⁠⁠⁠⁠⁠⁠⁠ or follow us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠social media⁠⁠⁠⁠⁠⁠⁠⁠⁠.

In today’s Midday Report, host Mandy Wiener covers the latest headlines, starting with growing fears among Soshanguve residents following the brutal murder of five local patrollers. As we mark World TB Day, Wiener looks at the impact of recent US funding cuts. In other developments, trials have been delayed due to ongoing water cuts, while hundreds of protesters have marched in Durban against illegal immigrants. Finally, Wiener wraps up with a roundup of the weekend's sports highlights. Listen live - The Midday Report with Mandy Wiener is broadcast on weekdays from noon to 1pm on 702 and CapeTalk.See omnystudio.com/listener for privacy information.

Health minister Dr Aaron Motsoaledi isn't mincing words. Speaking on World TB Day, he warned: “If you don't want to have TB, just stop breathing. As long as you breathe you will definitely get it — that's how big this problem is.”

As we mark World TB Day today, South Africa stands on the threshold of creating only the second tuberculosis vaccine ever, and the first in more than a century since the BCG vaccine in 1921. This is according to Professor Willem Hanekom - Director at the Africa Health Research Institute (AHRI). Hanekom says it is fitting that we can proudly say that Africa, primarily South Africa, is playing a great role in the development of a TB vaccine that holds the greatest promise since the invention of the BCG vaccine more than 100 years ago. Sakina Kamwendo spoke to Director at the Africa Health Research Institute (AHRI), Professor Willem Hanekom

Deputy President Paul Mashatile, will today lead the official World TB Day commemoration and launch the National End TB Campaign in KwaZulu-Natal. The event aims to highlight the devastating impact of tuberculosis and mobilize national efforts to eradicate it. This year's theme, 'Yes! You and I Can End TB – Commit, Invest, Deliver,' calls for urgent action. The campaign seeks to diagnose 250,000 new TB cases in 2025/26, targeting 5 million people with universal TB testing. For more on this Elvis Presslin spoke to Sihle Mahonga Ndawonde, TB Accountability Consortium project coordinator

Send us a textTuberculosis remains one of the deadliest infectious diseases globally, claiming approximately 3,400 lives daily. On this World TB Day episode, We speak with Professor Leigh Fairley, Director of Maternal and Child Health at Wits RHI and Associate Professor at the University of Witwatersrand, about groundbreaking research that could transform TB prevention.As a key figure in the M72 trial, she discusses the M72 trial, its significance in the fight against TB and the potential impact the vaccine will have in South Africa. Support the showFollow the show on:Twitter: @RootofscipodInstagram: @Rootofscipod YouTube: The Root Of The Science PodcastFacebook: The Root of The Science Podcast LinkedIn: The Root Of The Science PodcastWebsite

RaeAnn Tucker from the Henry and Stark County Health Departments joined Wake Up Tri-Counties to talk about National Public Health Week, World Tuberculous (TB) Day, Diabetes Day, Blood Draw, Well Water, and FIT Test Kits.

In this episode, released to coincide with World TB Day 2024, Dr Ben Warner discusses pulmonary tuberculosis (TB) with Dr David Connell. Dr David Connell first explains his personal interest in TB. They then discuss pulmonary TB in depth, including: epidemiology; pathogenesis, immune response, and transmission (a 'lymphatic disease with respiratory spread'); how TB presents and differential diagnoses; latent TB infection and reactivation; and management including the importance of the multidisciplinary team (MDT) and the role of public health in contact tracing and the end goal of elimination. Dr David Connell completed higher specialist training in Respiratory and General Internal Medicine in North-West London including at St.Mary's Hospital, where he completed a PhD in the immunology of Tuberculosis, before becoming a Consultant at Ninewells Hospital in 2017 where he has a specialist interest in Complex Pulmonary Infections and TB. He is Co-Chair of the Scottish Health Protection Tuberculosis Network and is a Clinical Service Advisor to the BTS MDR-TB Advice Service. Dr Ben Warner is a Respiratory Medicine Specialty Registrar with clinical and academic experience of global public health, having completed the LSHTM's East African Diploma in Tropical Medicine and then worked for 18 months in rural South Africa, where he encountered the sharp end of the global TB pandemic. He is currently undertaking a PhD in multimorbidity in Malawi as part of the Wellcome-funded Multimorbidity PhD Programme for Health Professionals fellow with the University of Glasgow. Recording date: 1 March 2024 -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: cme@rcpe.ac.uk

CEO of Proactive Health Solutions, Dr Fundile Nyati shines the spotlight on World TB day, an on what to make of news of a first new TB jab in over a century, the vaccine is said to trialled in SA soon.  See omnystudio.com/listener for privacy information.

In this episode of the Ask Theory podcast, Dr. Trisha Angelie Thadhani of Médecins Sans Frontières/Doctors Without Borders talks about tuberculosis in the Philippines, why TB is still a taboo topic for some, the issue of bedaquiline and how it affects TB treatment in the Philippines, current strategies for TB awareness and treatment, why World TB Day matters, and more. To learn more, visit: https://doctorswithoutborders-apac.org/en/our-work-on-tuberculosis This episode was made possible by the British Council Philippines, the United Kingdom's international organization for cultural relations and educational opportunities. Now on its fourth year, the British Council is accepting applicants for its Women in STEM Scholarship programme. For more information, visit the British Council Women in STEM website: https://www.britishcouncil.ph/study-uk/women-in-STEM #WomenInSTEM #STEMHasNoLimits

March 23rd marked World TB Day and the theme for this year is “'Yes! We can end TB!'. It aims to inspire hope and encourage high-level leadership, increased investments, faster uptake of new WHO recommendations, adoption of innovations, accelerated action, and multisectoral collaboration to combat the TB epidemic.It's no secret that African countries and scientists have always been at the forefront and big country advocates in the fight against one of the biggest silent killers of the 21st century. This is evident with the involvement of technology. On the show, our guest shares insights on these new tech solutions and innovations to eradicate TB. He is Snore WestgaardHe is the Chief Executive Officer of Humana People to People India (HPPI) and has been associated with HPPI for the last 18 years, as a Programme Director and then Chief Functionary. Since he began working with HPPI, the organisation has expanded from a small base to a 4000 people strong organisation reaching 2.8 million people over 100 locations today across 16 States with over 80 partners.He has spearheaded HPPI's programs under the PPP (Public Private Partnership Model) in Education with the vision to empower the knowledge base of the public schools and teacher training institutesThis show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/4432283/advertisement

March 23rd marked World TB Day and the theme for this year is “'Yes! We can end TB!'. It aims to inspire hope and encourage high-level leadership, increased investments, faster uptake of new WHO recommendations, adoption of innovations, accelerated action, and multisectoral collaboration to combat the TB epidemic.It's no secret that African countries and scientists have always been at the forefront and big country advocates in the fight against one of the biggest silent killers of the 21st century. This is evident with the involvement of technology. On the show, our guest shares insights on these new tech solutions and innovations to eradicate TB. He is Snore WestgaardHe is the Chief Executive Officer of Humana People to People India (HPPI) and has been associated with HPPI for the last 18 years, as a Programme Director and then Chief Functionary. Since he began working with HPPI, the organisation has expanded from a small base to a 4000 people strong organisation reaching 2.8 million people over 100 locations today across 16 States with over 80 partners.He has spearheaded HPPI's programs under the PPP (Public Private Partnership Model) in Education with the vision to empower the knowledge base of the public schools and teacher training institutes

March 23rd marked World TB Day and the theme for this year is “'Yes! We can end TB!'. It aims to inspire hope and encourage high-level leadership, increased investments, faster uptake of new WHO recommendations, adoption of innovations, accelerated action, and multisectoral collaboration to combat the TB epidemic.It's no secret that African countries and scientists have always been at the forefront and big country advocates in the fight against one of the biggest silent killers of the 21st century. This is evident with the involvement of technology. On the show, our guest shares insights on these new tech solutions and innovations to eradicate TB. He is Snore WestgaardHe is the Chief Executive Officer of Humana People to People India (HPPI) and has been associated with HPPI for the last 18 years, as a Programme Director and then Chief Functionary. Since he began working with HPPI, the organisation has expanded from a small base to a 4000 people strong organisation reaching 2.8 million people over 100 locations today across 16 States with over 80 partners.He has spearheaded HPPI's programs under the PPP (Public Private Partnership Model) in Education with the vision to empower the knowledge base of the public schools and teacher training institutes

Did you know that before COVID-19, tuberculosis was the leading infectious killer, even higher than HIV/AIDS? While it has now been overtaken by COVID-19, it doesn't mean TB is any less of a threat to public health than it used to be. In fact, many experts are concerned that the focus on COVID-19 has set us back on making progress with TB. So how do we get to the point where TB is a part of our history books? Is that possible with drug-resistant TB? We find out from Dr Ilaria Motta, TB Medical Advisor, MSF Access Campaign.Image Credit: Shutterstock

Cindy Long, Administrator of the USDA Food and Nutrition Service, says a new set of proposed school lunch guidelines are an important step to putting kids on a path to healthy lifestyles; Jeffrey Ekoma, ASTHO's Senior Director of Government Affairs, outlined Dr. Anne Zink's testimony to Congress yesterday in this week's “View from Washington D.C.” report; today is World TB Day, which is an opportunity to focus on the work to end the tuberculosis epidemic that claimed 1.6 million lives worldwide in 2021; and it's time to register for ASTHO's TechXpo and Futures Forum which is planned for May 23rd through the 25th in Chicago. USDA Webpage: Proposed Updates to the School Nutrition Standards World Health Organization Webpage: World Tuberculosis Day 2023 ASTHO Webpage: Public Health TechXpo and Futures Forum  

Guest: Harry Hausler is Chief Executive Officer at TB HIV Care and he joins Africa on to consider South Africa's TB recovery plan in the National Strategic Plan that was launched on International World TB Day today.See omnystudio.com/listener for privacy information.

Today, 24th March is World Tuberculosis Day, so there isn't a better time to talk about TB and the different ways to fight it. Our expert - Senia Rosales-Klintz tells us that this indeed is the plan, and with a deadline for 2030. Can it be done? If you would like to read the latest news on TB and see the details of the World TB Day campaign, visit our website here. For general information about ECDC, please visit ecdc.europa.eu, or follow us on social media.

2:57 Labiotech.eu news4:17 PBD Biotech14:52 AAHI29:36 TB AllianceMarch 24 is World Tuberculosis Day. To mark the occasion, we have conversations with Christopher Fox, senior vice president, formulations, at the Access to Advanced Health Institute; TB Alliance CEO Mel Spigelman; and Jane Theaker, CEO of PBD Biotech.This episode of the podcast is sponsored by Samplix.World Tuberculosis DayTuberculosis is a leading infectious disease. According to the WHO, 10.6 million people became ill with the disease in 2021, and there were 1.6 million deaths from tuberculosis. The theme for World TB Day 2023 is Yes! We can end TB!It aims to inspire hope and encourage high-level leadership, increased investments, faster uptake of new WHO recommendations, adoption of innovations, accelerated action, and multisectoral collaboration to combat TB. TB AllianceTB Alliance is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight TB. Through innovative science and with partners around the globe, the organization aims to ensure equitable access to faster, better TB cures that will advance global health and prosperity. TB Alliance operates with support from various global governments as well as the Bill & Melinda Gates Foundation, Cystic Fibrosis Foundation, the Global Health Innovative Technology Fund, and the United States Agency for International Development. Access to Advanced Health InstituteA potential new vaccine for tuberculosis has been developed by the Access to Advanced Health Institute in Seattle, a nonprofit biotech research institute.The results of a phase 1 clinical trial were published earlier this month in the journal Nature Communications.PBD BiotechPBD Biotech has developed a rapid screening blood test for identifying people with the disease as well as a subgroup with pre-clinical infection at higher risk of developing the disease.The company said this has the potential to revolutionize the management of TB. Biotech's Actiphage blood test is sensitive and specific, and clinical studies at the Leicester Respiratory NIHR Biomedical Centre have shown it is able to diagnose patients with pulmonary TB and identify contacts with recent exposure that have very early stage infection and may be at higher risk of developing TB in the future. By enabling rapid screening of a population for TB, Actiphage offers a breakthrough in disease prevention and treatment. Further trials of Actiphage are currently running in the U.K., South Africa and Zambia.

In this episode we are celebrating World TB Day, this year's campaign is ‘YES! We Can End TB' and is all about solidarity and collective action. It centres on the increased engagement of those affected by TB, communities and civil society that are leading the movement towards ending this disease.This episode features the LIGHT consortium which aims to provide new evidence on the effectiveness of different gender-sensitive pathways and approaches to health for those with TB in urban, HIV-prevalent settings across Uganda, Nigeria, Malawi and Kenya. Our co-host Samara Barnes, who has lived experience of TB in the UK, speaks with researchers Toyosi Adekeye in Nigeria and Jasper Nidoi in Uganda from the LIGHT consortium about the ways they are enaging with affected communities in their work. Samara also shares her experience from the UK and the conversation reflects on the differences of TB across contexts. In this episode we are celebrating World TB Day, this year's campaign is ‘YES! We Can End TB' and is all about solidarity and collective action. It centres on the increased engagement of those affected by TB, communities and civil society that are leading the movement towards ending this disease.This episode features the LIGHT consortium which aims to provide new evidence on the effectiveness of different gender-sensitive pathways and approaches to health for those with TB in urban, HIV-prevalent settings across Uganda, Nigeria, Malawi and Kenya. Our co-host, Samara Barnes, who has lived experience of TB in the UK speaks with researchers Toyosi Adekeye in Nigeria and Jasper Nidoi in Uganda from the LIGHT consortium about the ways they are engaging with affected communities in their work. Samara also shares her experience from the UK and the conversation reflects on the differences of TB across contexts. This episode features:Samara Barnes Affected Community Co-Lead at the UK Academics and Professionals to End TB (UKAPTB)Samara is an Affected Community Co-Lead at the UK Academics and Professionals to End TB (UKAPTB). She was diagnosed with active pulmonary TB in late 2015 and it was discovered she was also drug resistant as her treatment went on. Until that point, Samara knew little about the illness apart from the fact that her Grandad had died of TB many years previously. Samara has raised money for TB Alert and has been part of their peer supporter programme too. She has also studied and written papers on the Global disparities in TB treatment. It is important for Samara to raise awareness of this illness, be an advocate for reducing the stigma surrounding it and to encourage decision makers in the UK to ensure they keep to their commitment of a year on year reduction of TB and contribute to the WHO's commitment to eliminate TB by 2035. Samara works for a national children's charity and is also a borough and county councilor.Dr Jasper Nidoi - Early Career Researcher, Liverpool School of Tropical Medicine, U.K and Makerere University Lung Institute, Uganda.Jasper Nidoi is a Ugandan medical doctor with specialist training in health economics and health systems and policy research from Karolinska Institutet, Sweden. For over 5 years, she has been involved in the design and implementation of clinical trials that have evaluated drugs for the prevention and treatment of infectious diseases in Uganda. She is a health economist on a clinical trial that is evaluating the effectiveness and cost-effectiveness of standardized medication for MDR-TB. She was a co-investigator in a study that evaluated the impact of socio-economic factors on tuberculosis treatment outcomes in one of the poorest regions in Uganda. Her research interests are in the socio-economic determinants of health as they pertain to tuberculosis and the use of decision-analytic models to systematically synthesise data for the economic evaluation of...

 Health NPO, Right to Care says South Africa has one of the highest TB rates in the world. It says the country is also under-diagnosing the disease.  Today marks World TB Day and  this years theme is titled "  'Yes! You and I can end TB. Sakina Kamwendo spoke to Dr Lucy Connell, TB  programme lead at health NPO, Right to Care.

Public Health Midwest is asking the people of Limerick and the Midwest to be aware that "tuberculosis is a disease that remains in our community".Dr Marie Casey joins Joe ahead of World TB Day on March 24th to discuss this. Hosted on Acast. See acast.com/privacy for more information.

The National Aids Commission announces reduction in HIV prevalence rate, the Ministry of Health commemorates World TB Day, Parliament amends 2016 Land Bill, government recruits over 2,000 teachers, man arrested for fake banknotes, ESCOM units sold on black market, Department of Tourism launches new Cruise Ship, and much more!Thanks for tuning in!Let us know what you think and what we can improve on by emailing us atmalawi@rorshok.com or follow us on Instagram or Twitter @RorshokMalawiLike what you hear? Subscribe, share, and tell your buds.If you have a 5,000 Kwacha banknote, and its serial number is AA7915614, return it to the Reserve Bank of Malawi as soon as possible because it is fake.Oops! It looks like we made a mistake.In 06:24, the reader said "7 million" instead of "17 million".Sorry for the inconvenience! 

In this week's Podcast from Washington, NACCHO Government Affairs team members Ian Goldstein and Kerry Allen summarize the status of the PREVENT Pandemics Act. They also discuss the administration's urging of Congress to pass additional COVID-19 emergency supplemental funding. Finally, they cover a study released by Johns Hopkins Bloomberg School of Public Health that identified reports of harassment across local health departments.  Later in the program, in recognition of World TB Day, Ian speaks with Deputy Public Health Director and Director of Community Health Services for Genesee and Orleans Counties Brenden Bedard. They discuss tuberculosis (TB) programs in his rural jurisdiction that contains a large population of migrant workers and the need to develop partnerships to address TB needs in the community. Brenden also describes how COVID-19 affected his health department's TB program. 

དེ་རིདང་ཕྱི་ཟླ་ ༣  ཕྱི་ཚེས་ ༢༤  ཉིན་མོ་འདི་ནི་འཛམ་གླིང་འཕྲོད་བསྟེན་ལྷན་ཚོགས་ཀྱིས་གཏན་འབེབས་གནང་བའི་ World TB Day འམ་འཛམ་གླིང་ཊི་སྦི་ཉིན་མོ་དང་བསྟུན་བཞུགས་སྒར་དབུས་བདེ་ལེགས་སྨན་ཁང་གིས་རྡ་སྟེང་བོད་ཁྱིམ་སློབ་གྲྭར་ཊི་བི་རྩ་འགོག་གི་ལས་གཞི་དང་འབྲེལ་བའི་དེང་དུས་ཚད་མཐོའི་གློག་པར་འཕྲུལ་ཆས་གསར་པ་ཞིག་དབུ་འབྱེད་ཀྱིས་སློབ་མ་རྣམ་པར་ཊི་སྦི་ནད་རྟགས་ཡོད་མེད་བརྟག་དཔྱད་གནང་འགོ་བཙུགས་སོང་།དེ་རིང་སྔ་དྲོ་ཚོུད་ ༡༡།༣༠ ཡོལ་ཙམ་ལ་རྡ་སྟེང་བོད་ཁྱིམ་སློབ་གྲྭའི་བདེ་སྐྱིད་ཚེ་རིང་ཚོགས་ཁང་ནང་དབུ་འབྱེད་གནང་བའི་དེང་དུས་ཚད་མཐོའི་གློག་པར་འཕྲུལ་ཆས་དེ་བོད་མི་མང་སྤྱི་འཐུས་ཚོགས་གཙོ་མཁན་པོ་བསོད་ནམས་བསྟན་འཕེལ་མཆོག་སྐུ་མགྲོན་དུ་ཆེད་ཕེབས་ཀྱིས་བདེ་ལེགས་སྨན་ཁང་གི་འགན་འཛིན་བོད་མི་མང་སྤྱི་འཐུས་ཟླ་བ་ཕུན་སྐྱིད་ལགས་དང་ལས་གཞི་དེའི་འགན་བཞེས་མཁན་བདེ་ལེགས་སྨན་ཁང་གི་སྨན་པ་བསོད་ནམས་སྟོབས་རྒྱལ་ལགས་ཀྱི་གཙོས་པའི་ཕྱག་རོགས་ལས་བྱེད་དང་སྨན་ཞབས་པ། ལྷག་དོན་རྡ་སྟེང་བོད་ཕྲུག་ཁྱིམ་སྡེའི་སྤྱི་ཁྱབ་ཡིག་ཚང་གི་མཛད་གཙོ་རྣམ་པ་སོགས་ལྷན་ཞུགས་གནང་སོང་།གཞི་རྩའི་བཞུགས་སྒར་དབུས་བདེ་ལེགས་སྨན་དང་ཨ་རིའི་ John Hopkins གཙུག་ལག་སློབ་གཉེར་ཁང་གཉིས་ནས་གློ་ནད་ཊི་སྦི་དང་འབྲེལ་བའི་ལས་གཞི་ཐོག་མར་ ༢༠༠༨ ལོ་ནས་དབུ་འཛུགས་གནང་འདུག་པ་དང་། དམིགས་བསལ་ཕྱི་ལོ་  ༢༠༡༧ ལོ་ནས་ཚོགས་པ་དེ་གཉིས་མཉམ་འབྲེལ་ཐོག་ནས་བོད་པའི་སྤྱི་ཚོགས་ནང་དུ་ Zero TB འམ་གློ་ནད་ཊི་སྦི་རྩ་མེད་ཅེས་པའི་འཕྲོད་བསྟེན་གྱི་ལས་གཞི་དེ་དབུ་འཛུགས་གནང་སྟེ་ད་བར་རྒྱ་གར་ནང་གི་བོད་པའི་སློབ་ཁག་དང་དགོན་ཁག་མང་དག་ཅིག་ནང་རིན་མེད་ཐོག་ནས་ཊི་སྦི་ནད་རྟགས་ཡོད་མེད་ཀྱིས་བརྟག་དཔྱད་གནང་ཟིན་ཡོད་ཀྱང་འདས་པའི་ལོ་གཉིས་ཙམ་ནས་ཏོག་དབྱིབས་གཉན་རིམས་ཁྱབ་གདལ་རྐྱེན་གྱིས་ལས་གཞི་དེ་མཇུག་སྐྱོང་མ་ཐུབ་པར་ལྷག་ཡོད་པ་རེད།   The post རྡ་སྟེང་བོད་ཁྱིམ་དུ་ཊི་སྦི་ནད་རྟགས་ཡོད་མེད་བརྟག་དཔྱད་འགོ་འཛུགས་ཀྱིས་འཛམ་གླིང་ཊི་སྦི་ཉིན་མོ་སྲུང་བརྩི། first appeared on vot. The post རྡ་སྟེང་བོད་ཁྱིམ་དུ་ཊི་སྦི་ནད་རྟགས་ཡོད་མེད་བརྟག་དཔྱད་འགོ་འཛུགས་ཀྱིས་འཛམ་གླིང་ཊི་སྦི་ཉིན་མོ་སྲུང་བརྩི། appeared first on vot.

Guest: Dr Jody  Boffa | Research Fellow  at Centre for Rural Health, University of KwaZulu-Natal See omnystudio.com/listener for privacy information.

Every year we commemorate World TB Day on March 24, the anniversary of the day Dr. Robert Koch first announced that he discovered Mycobacterium tuberculosis, the bacillus that causes TB. This World TB Day, we are sharing an insightful conversation between two TB laboratory leaders: Angie Schooley, B.S. MT(ASCP), Mycobacteriology/Mycology Unit Manager, Michigan Department of Health & Human Services  and Caitlin Miranda, M(ASCP), Microbiologist III, Oregon State Public Health Laboratory. Links: Oregon State Public Health Laboratory Oregon Public Health Division Tuberculosis Program Michigan Department of Health & Human Services Tuberculosis Control Program Bovine TB testing of wild deer wraps up after disease found at Michigan cervid farms (February 8, 2022) What is Extensively Drug-Resistant Tuberculosis (XDR TB)? (CDC Fact Sheet) 12th National Conference on Laboratory Aspects of Tuberculosis World TB Day APHL Tuberculosis webpage APHL Blog – Tuberculosis blog posts Lab Culture Ep. 8: Leaders for a TB free world  

This Thursday, 24 March is World Tuberculosis Day. An estimated 9.9 million people fell ill with TB in 2020 and 1.5 million people died from the disease. TB continues to be a blight in the Indo-Pacific region, particularly in Papua New Guinea, Indonesia, Kiribati and the Republic of the Marshall Islands. Papua New Guinea bears the largest burden of disease in the Pacific, including a heavy burden of multidrug-resistant TB. In 2020 almost 30,000 cases were notified there, including 600 cases of multidrug-resistant and extensively drug-resistant TB.But TB is preventable and curable. So why is it still one of the most infectious and deadly diseases on the planet? On today's episode we are joined by three experts who are on the front line of trying to bring an end TB.Dr Mel Spigelman is the President and Chief Executive Officer of the Global Alliance for TB Drug Development – the TB Alliance – and a Member of its Board of Directors. In his time at the TB Alliance, Dr Spiegelman has been a leader in developing a regimen-based paradigm of TB drug development and leading the TB drug research field.Dr Margaret Kal is the director of the PNG National TB Program (NTP). In this role, Dr Kal is responsible for the development of all national TB guidelines, policies, research, national program reviews and all other plans and policies for TB prevention and care in PNG. Australia's Department of Foreign Affairs and Trade supports the work of the NTP.And finally, Dr Philipp du Cros is an Infectious Diseases Specialist in TB Elimination and Implementation Science at the Burnet Institute. He has extensive experience in the management of TB/HIV programs and has worked with MDR TB programs across Tajikistan, Uzbekistan, India, Myanmar, Uganda, Swaziland and Zimbabwe.The theme of World TB Day 2022 - ‘Invest to End TB. Save Lives.' We talk to all of our guests on this episode about practical ways the global community can invest to end TB and the urgent need to invest resources to ramp up the fight against TB.We hope you learn something from the conversation and join the fight to end TB @TBAlliance @CentreHealthSec

A message from the FNHA on World TB Day, an annual event aimed at spreading awareness of the ongoing impacts of this disease.

It's described as PNG's 'number one killer' with thousands acquiring the disease every year. Tuberculosis has long posed a serious threat to the people of Papua New Guinea but the Covid-19 pandemic has made it worse. This coming Thursday is World TB Day but the civil society group, Businesses4Health, or B4H, want to see a greater emphasis on raising awareness about the disease. Project manager for B4H, Ann Clarke, told Don Wiseman that they want to see a year long focus on the deadly disease. She explained how Covid-19 had affected TB treatment.

These podcasts are linked to my blog Notes from a small scientist. In this episode, to celebrate World TB Day on the 24th March, I discuss the disease tuberculosis and the bacteria that causes it, Mycobacteria tuberculosis. I explain why TB is so hard to treat, why it's such a pain to work with and why we still haven't got rid of it yet! But don't worry, there's always hope for the future in the shape of research! All my posts have links to online resources that you might find useful, and you can find the link to this particular post here.

For tonight's Medical Matters we are joined by Dr. Jennifer Furin, infectious diseases clinician currently supporting the drug-resistant TB activities of Doctors Without Borders in Khayelitsha to focus on the gaps in treatment of TB in children and adolescents as a follow up to World Tuberculosis Day (24 March 2021) See omnystudio.com/listener for privacy information.

In Commemoration of World T.B Day on the 24th of March 2021, the President's Emergency Plan For AIDS Relief (PEPFAR) through USAID and CDC Zimbabwe, made possible the following programme, which was implemented by various partners.

Bonolo Nkosi is talking to Seun Makgoroma, Wellness co-ordinator at South African National Tuberculosis Association about World TB Day. They look at the aspects of what is TB, its causes, why world TB Day, how is TB cured, and what to do to stay safe.

Bonolo Nkosi is talking to Seun Makgoroma, Wellness co-ordinator at South African National Tuberculosis Association about World TB Day. They look at the aspects of what is TB, its causes, why world TB Day, how is TB cured, and what to do to stay safe.

To mark World TB Day, Katherine E. Bliss and J. Stephen Morrison speak with Adrian Thomas, TB expert and leader of global strategy at Johnson & Johnson Global Health. Every year, TB kills an estimated 1.4 million people and infects another 10 million people, with about 400,000 of those cases resistant to two or more drugs. Covid-19 has disrupted health systems and displaced funding and frontline staff away from TB, which models estimate will cause an additional million cases per year over the next five years. In this episode, we talk to Adrian about the grave impact the pandemic is having on global TB efforts, how to build local health security capacities that control TB and respond to future outbreaks, how international scientific partnerships speed up R&D and create platforms with broad applications, and the recent emergency use authorization by the FDA of J&J's Covid-19 vaccine.   Adrian Thomas is Vice President for Strategy and External Affairs at Johnson & Johnson Global Health. The views expressed in the podcast are personal and not those of his employer.

Each year March 24 is observed as World Tuberculosis (TB) Day to raise public awareness about the devastating health, social and economic effects of TB. This day is also used to increase the efforts to end the global TB epidemic. World TB Day is one of the eleven official global public health campaigns marked by the World Health Organization (WHO) March 24 is selected in the remembrance of the same day in 1882 when Dr. Robert Koch announced that he had discovered the bacterium that causes TB. Compiled & Presented by : Abdul Credits, Image by oracast from Pixabay

In 2019, an estimated 26 lakh people fall sick with TB in India. Of these about 1.24 lakh have drug resistant tuberculosis.  On March 24, which is World TB Day, Suno India's Menaka Rao speaks with Meera Yadav, a TB survivor and activist. She got TB in 2013, a few months after she delivered a child. She then suffered 8 years taking treatment for TB during which her lung was removed via surgery. She now works with a nonprofit with one of the government projects helping TB patients who seek treatment in the private sector. She recently moved the Bombay High Court along with health rights activist Brineille D'Souza with the plea that two drugs– Bedaquiline and Delamanid –which used to treat drug-resistant tuberculosis should be produced in India so that more patients can access it.  Additional reading: WHO Operational Handbook on Tuberculosis, 2020 Treating TB is hard, it is worse if you are a woman Why TB patients aren't getting the drugs they need See sunoindia.in/privacy-policy for privacy information.

139 साल पहले टीबी के बैक्टीरिया की खोज हुई, आज भी इसके सबसे ज्यादा मरीज भारत में मिलते हैं

Martin McKee discusses the current state of vaccine rollout in Europe and the challenges ahead, and the Director of WHO's Global TB Programme, Tereza Kasaeva, talks about how COVID-19 has stalled progress on tackling tuberculosis.

This Wednesday is World TB Day. An estimated 1.4 million fewer people received care for TB in 2020 compared with 2019, and we fear that more than half a million more people may have died. The gap between the number of vaccines administered in rich countries, and the number of vaccines administered through COVAX is growing every day, and becoming more grotesque every day.WHO is continuing to work day and night to find solutions to increase the production and equitable distribution of vaccines. I’m pleased to announce that a shortlist has now been selected from 1200 entries for the WHO Health for All Film Festival. The films are available on the WHO YouTube channel.

World TB Day is March 24th, and we celebrated by interviewing John and Avril Thomas, founders of Living Hope. For the past 20 years Living Hope has faithfully served the people of Cape Town, South Africa through various services such as healthcare, substance abuse recovery, life skills, and agricultural training. Kelly spent the summer of 2008 with the nurses in their healthcare center, and it was there that she developed her passion for community health nursing. This is a special episode. We know you’ll love hearing it. Visit http://www.livinghope.co.za/ for more information about Living Hope.Email volunteer@livinghope.co.za if you’re interested in volunteer opportunities.Visit https://www.cdc.gov/tb/ for more information about TB.

ირაკლი აბრამიშვილი და დავით დათუნაშვილი წარმოგიდგენთ : Masterknot - ToBe Continued 2018 - World TB Day music marathon ცოცხალი ჩანაწერები. ირაკლი აბრამიშვილი / Live. მაუწყებლობის ძირითადი ენა ქართული. Community Radio Tbilisi Wednesday/12.02.2020/17:00-19:00 local TBS time Irakli Abramishvili and Davit Datunashvili presents: Masterknot - ToBe Continued 2018 - World TB Day music marathon Live Recording; Irakli Abramishvili / Live

March 24th was World TB Day, a World Health Organization-designated day of advocacy to raise awareness about the devastating health, social, and economic consequences of tuberculosis. In this episode of Take as Directed, host Steve Morrison is joined by Dr. Eric Goosby, the UN Special Envoy on Tuberculosis. Dr. Goosby recently led a Lancet Commission on tuberculosis, a two-year effort that has culminated in a longform report titled “Building a tuberculosis-free world”, and spoke about some of the main findings of the report and what the next steps are in creating a world free of TB.

March 24th was World TB Day, a World Health Organization-designated day of advocacy to raise awareness about the devastating health, social, and economic consequences of tuberculosis. In this episode of Take as Directed, host Steve Morrison is joined by Dr. Eric Goosby, the UN Special Envoy on Tuberculosis. Dr. Goosby recently led a Lancet Commission on tuberculosis, a two-year effort that has culminated in a longform report titled “Building a tuberculosis-free world”, and spoke about some of the main findings of the report and what the next steps are in creating a world free of TB.

Theme of World TB Day 2019. It's TIME

Keertan Dheda joins The Lancet Respiratory Medicine to discuss the hottest topics in TB control and treatment.

Every year on March 24, APHL recognizes World TB Day, a day to focus on the valuable work of our members and partners. While tuberculosis is often considered a disease of the past, it is resurging and presenting significant new public health challenges including drug resistance. This World TB Day, we are sharing an insightful conversation between two TB laboratory leaders: Dr. Marie-Claire Rowlinson, assistant laboratory director, Bureau of Public Health Laboratories, Florida Department of Health and Dr. Beverly Metchock, team lead, TB Reference Laboratory, CDC Division of Tuberculosis Elimination.    Links APHL TB program World TB Day Resources National Tuberculosis Controllers Association The Tenacity of Tuberculosis: MDR-TB (blog post)

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista Migliori about the following articles. ---- Borisov SE, Dheda K, Enwerem M, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J 2017; 49: 1700387. Cabibbe AM, Sotgiu G, Izco S, et al. Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens. Eur Respir J 2017; 50: 1702292. Falzon D, Schünemann HJ, Harausz E, et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 2017; 49: 1602308. Guglielmetti L, Jaspard M, Le Dû D, et al. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J 2017; 49: 1601799. Miotto P, Tessema B, Tagliani E, et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50: 1701354. Pontali E, Sotgiu G, Tiberi S, et al. Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence. Eur Respir J 2017; 50: 1701462. Van der Werf MJ, Hollo V, Ködmön C, et al. Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union. Eur Respir J 2017; 49: 1601992.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista Migliori about the following articles. Borisov SE, Dheda K, Enwerem M, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J 2017; 49: 1700387. Cabibbe AM, Sotgiu G, Izco S, et al. Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens. Eur Respir J 2017; 50: 1702292. Falzon D, Schünemann HJ, Harausz E, et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 2017; 49: 1602308. Guglielmetti L, Jaspard M, Le Dû D, et al. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J 2017; 49: 1601799. Miotto P, Tessema B, Tagliani E, et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50: 1701354. Pontali E, Sotgiu G, Tiberi S, et al. Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence. Eur Respir J 2017; 50: 1701462. Van der Werf MJ, Hollo V, Ködmön C, et al. Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union. Eur Respir J 2017; 49: 1601992.

Tune in to the Health and Safety podcast to hear about World TB Day, an upcoming blood drive, springtime weather and 9-1-1 Education Month.

Tune in to the Health and Safety podcast to hear about World TB Day, an upcoming blood drive, springtime weather and 9-1-1 Education Month.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. On the occasion of World TB Day 2017, chief editor Marc Humbert discusses the publication of a number of new articles on tuberculosis with Prof. G.B. Migliori from the Fondazione S. Maugeri Care and Research Institute, Italy.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. On the occasion of World TB Day 2017, chief editor Marc Humbert discusses the publication of a number of new articles on tuberculosis with Prof. G.B. Migliori from the Fondazione S. Maugeri Care and Research Institute, Italy.

To mark World TB Day and the launch of a major new commission on drug-resistant tuberculosis, The Lancet Respiratory Medicine's April issue is about TB. In this podcast, Aaron van Dorn interviews Stephen Gillespie about the special issue

Elizabeth Wangeci's story is a remarkable one. Against the odds, Elizabeth, from Nairobi, was the first person to survive one of the deadliest forms of drug-resistant tuberculosis in Kenya. In the first episode of the second series of Everyday Emergency, on World TB Day 2017 we speak to Elizabeth nearly one year after being cured. We also hear from Mark Sherlock, an MSF TB doctor who works not far from Elizabeth in Nairobi. "Everyday Emergency" is a podcast from MSF. In each episode, we bring you true stories from the frontline of humanitarian emergencies across the world. From the conflict in Syria to the refugee crisis in Europe, we’ll be talking to people with some incredible stories that may just change your outlook on life, or at least, for a moment, put things into perspective. In each podcast you’ll hear a true story written by an MSFer on the ground, read by an actor. We’ll then get them into the studio at MSF HQ for a chat about their time with MSF. Subscribe through iTunes or your favourite podcast provider, and find out more at msf.org.uk/podcasts Please leave comments on our Facebook page, or on Twitter. facebook.com/msf.english twitter.com/msf_uk

A new Multi Drug Resistance TB treatment will soon be rolled out in four provinces. About 400 patients will take part in the research. The drug is produced by Japan and has been approved for treating MDR-TB in the European Union, Japan and the Republic of Korea. As the world celebrates World TB Day today, Health Minister Aaron Motsoaledi has launched the Delamanid Clinical Access Programme for the treatment of MDR-TB. This is part of initiatives to manage and treat Tuberculosis in South Africa. Tsepiso Makwetla spoke to Deputy Director - General for HIV/AIDS, TB and Maternal, Child and Womens Health in the National Department of Health Dr Yogan Pillay

On Thursday 24th March, Radio Harrow hosted a special 8-hour broadcast in aid of World Tuberculosis (TB) Day. The special show was a culmination of 6 weeks of raising awareness about Tuberculosis in Harrow as part of Voluntary Action Harrow’s recent ‘TB Awareness Grant’. On World TB Day, the 8-hour show featured a variety of guests including a number of former patients speaking about their experience with TB. We also featured interviews with staff at Northwick Park Hospital’s Infectious Diseases Department, including the lead nurse specializing in TB and the TB consultant, Dr McGregor.

More children are at risk of being infected with tuberculosis globally due to a shortage of the BCG vaccine. BCG is the only vaccine available to protect against the disease. However, its shortage poses a major threat to the lives of many children exposed to the disease globally, including in South Africa. As the international community marks World TB Day today (Thursday 24 March), pharmaceutical companies say they don't make a profit from producing the TB vaccine - hence the shortage. Senior Journalist Thabile Mbhele reports…

To mark World TB Day today, Health Minister Dr Aaron Motsoaledi, will launch a massive National TB Screening and testing Campaign in the North West Province. South Africa is one of the countries with the highest burden of TB in the world. Sakina Kamwendo spoke to Minister Motsoaledi

Read the full story with photos at: Otsuka working Towards Overcoming Tuberculosis On March 24th – World TB Day – we are reminded of the 9 million people who become infected with tuberculosis (TB) every year, their challenges and their hope for cure. We at Otsuka remember this every day. It is the driving force behind our commitment to discovering new tools to eliminate TB in our lifetime. As the world’s leading private investor in TB research and development, it has been our goal for the past 40 years to find new, effective solutions to eliminating this disease that claims 1.5 million lives a year. We know that TB can affect anyone, anywhere in the world. That is why this year, we focus on those who are truly on the front lines of this disease – the healthcare workers, the patients, and their families. Each day this week we will profile stories of those who are making a difference in this fight and the inspiration they provide to others here. People such as Dasha and Grisha Lavrushiny, a young married couple from Russia, who have both struggled with TB, including the extensively-drug resistant form of it, but in the end have won the battle. Today, they are helping others receive correct diagnosis and treatment. Li Lulu, a young mother from China, developed TB meningitis, a particularly dangerous type of TB, right after giving birth. The encouragement and support of her family had given her the strength needed to complete treatment and today she is cured. The support of loved ones and the dedication of healthcare workers on the frontlines of the battle, such as Stuart Pancho, a registered nurse from the Philippines who leads trainings for other healthcare workers. The personal bonds they have established with their patients have proven essential to their treatment success. Though treatment for TB may be complicated and lengthy, it is a curable disease. Yet an estimated 3 million people a year go undiagnosed or untreated. Much progress remains to be done until every person is correctly diagnosed, treated and cured. We at Otsuka are committed to continuing our efforts so that, ultimately, we can live in a world free from TB.

ERJ Chief Editor Marc Humbert talks to Associate Editor G.B. Migliori about a new framework for eliminating tuberculosis in low-incidence countries.

Dr. Lee Reichman's remarks at the 2nd Annual New York City World TB Day Rally on March 22, 2014.

What are the best ways to control the global problem of tuberculosis? Professor Helen McShane from the Jenner Institute tells us about the MVA85A tuberculosis vaccine from her lab that’s currently undergoing large-scale clinical trials and the impact it could have on the incidence of TB around the world. This episode of Microbe Talk has been produced for World TB Day on Saturday 24 March.

John McConnell discusses a tuberculosis themed issue ahead of World TB Day on March 24.